Psoriatic arthritis

Journal of the Royal Society of Medicine

Volumn 93, Issue 8, 2000, Pages 412-415

  Pitzalis, C ^a   Pipitone, N ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; CALCITRIOL; CYCLOSPORIN; GOLD DERIVATIVE; HLA B27 ANTIGEN; KETOCONAZOLE; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PSORALEN; RETINOID; SALAZOSULFAPYRIDINE; STEROID; SULFAMIDE DERIVATIVE;

DISEASE CLASSIFICATION; HUMAN; NEPHROTOXICITY; PATHOGENESIS; PHOTOCHEMOTHERAPY; PROGNOSIS; PSORIASIS; PSORIATIC ARTHRITIS; REVIEW; ULTRAVIOLET A RADIATION;

EID: 0033845716     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1177/014107680009300806     Document Type: Review

References (33)

1. ARA nomenclature and classification of arthritis and rheumatism (tentative)
2. A unifying concept for the spondyloarthropathies
3. Classification of inflammatory arthritis by enthesitis
4. Psoriatic arthritis. Diverse and sometimes highly destructive
5. Psoriatic arthritis
6. Psoriatic arthritis. Clinical manifestations
7. Psoriatic arthritis: Outcome of disease subsets and relationship of joint disease to nail and skin disease
8. Psoriatic arthritis
9. Clinical indicators of progression in psoriatic arthritis: Multivariate relative risk model
10. Mortality studies in psoriatic arthritis: Results from a single outpatient center. II. Prognostic indicators for death
11. The role of HLA antigens as indicators of disease progression in psoriatic arthritis. Multivariate relative risk model
12. HLA markers and progression in psoriatic arthritis
13. Skin and joint disease in psoriatic arthritis: What is the link?
14. Value of synovial fluid interleukin-1 beta determination in predicting the outcome of psoriatic monoarthritis
15. Psoriatic arthritis
16. Psoriatic arthritis
17. Clinical, radiographic and HLA associations as markers for different patterns of psoriatic arthritis
18. Isolated peripheral enthesitis and/or dactylitis: A subset of psoriatic arthritis
19. The prevalence of sacroilitis in psoriatic arthritis; new perspective from a large, multicenter cohort. A Department of Veterans Affairs Cooperative Study
20. Psoriatic arthritis. Genetics and HLA antigens
21. The immunopathology of psoriasis
22. Cutaneous lymphocyte antigen-positive T lymphocytes preferentially migrate to the skin but not to the joint in psoriatic arthritis
23. Sulfasalazine in the treatment of spondyloarthropathy. A randomized, multicenter, double-blind, placebo-controlled study
24. The use of sulfasalazine in psoriatic arthritis: A clinic experience
25. Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: A one-year prospective study
26. Low-dose short-term cyclosporine versus etretinate in psoriasis: Improvement of skin, nail, and joint involvement
27. Sustained renal function loss in psoriasis patients after withdrawal of low-dose cyclosporin therapy
28. Combination therapy with cyclosporin in rheumatoid arthritis
29. The role of tumor necrosis factor antagonism in clinical practice
30. Comparative study of the clinical efficacy of four DMARDs (leflunomide, methotrexate, cyclosporine, and levamisole) in patients with rheumatoid arthritis
31. A systematic review of five systemic treatment for severe psoriasis
32. An update on vitamin D3 analogues in the treatment of psoriasis